Get in touch with usOur revolutionary software is a tool that delineates organs at risk and target volumes with the help of Artificial Intelligence.
Mediq RT reduces the contouring time by an average of 92.5%. This will decrease the time between diagnosis and treatment, increasing the survival rate of the patients.
Mediq RT has higher accuracy and objectivity than manual contouring while being less prone to errors.
Mediq RT compensates for the lack of medical staff by allowing clinics to treat more patients with the same number of radiation oncologists.
Mediq RT software runs this process automatically, allowing doctors to treat more patients.
Using Deep Learning pipelines for aiding the diagnosis process
Bringing the latest technology advancements closer to healthcare
Brining the latest innovations in research closer to the industry
With our collective intelligence and deviceful spirit, we deliver the best AI-based solutions for enhancing the quality of the healthcare industry.
Mediq RT reduces the time needed to elaborate the treatment plan by using Artificial Intelligence to contour organs-at-risk and target volumes on CT scans
Allow doctors to communicate effectively by using a centralized platform and speeding up their work using our pipeline
A Doctor with the help of Deep Learning algorithms will achieve faster and more robust results than using traditional methods.
Mediq RT continues to learn even after it is deployed
Doctors can adjust contours in assisted by the AI with a few clicks.
Our state-of-the-art architectures enable robust and high accuracy delineation
We use our unique blend of expertise in the fields of AI, medicine, and business to shape the future of radiotherapy.
Even though Mediq RT is used by radiation oncologists, cancer patients are the ultimate beneficiaries.
State-of-the-art solution
An average of €150,000 added value per year
2 hours of tedious work reduced to 2 minutes
Quicker and more robust treatment planning
Interested in working together or simply hearing more? Send us a note and we’ll get back to you.